BS Medicine Podcast
Hosted by
James McCormack
and
Mike Allan
.
These podcasts promote healthy skepticism and critical thinking, with the majority presented in a case-based format.
Listen Now
Recommended Listening
Episode 444: Hydroxychloroquine with or without azithromycin for COVID-19
In episode 444, James and Mike wade into the evidence quagmire around hydroxychloroquine and COVID-19. The bottom line is the evidence will likely be different around the time you listen to the podcast. So listen quickly. Show notes 1)Tools for Practice...
Episode 443: Electronic Cigarettes - Hoot that helps, hurts, or just hype?
In episode 443, James and Mike continue with Mike Kolber and we discuss the evidence around electronic cigarettes and their use for smoking cessation. Overall, the podcast ends up being smoking hot in so many ways. Show notes Tools for Practice...
Episode 442: Are biosimilars similar to biologics for inflammatory conditions?
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. Show notes Tools for Practice...
Episode 441: Guidelines could be so much better, but here is why they aren’t, yet
In episode 441, James and Mike revisit the problem with guidelines. We talk about recent writings on the issues around guidelines. We discuss the main problems and believe it or not we give advice and suggestions for how to make them better. Show notes 1) Health Affair...
Episode 440: Putting the FUN in Fungi: Toenail onychomycosis treatments
In episode 440, Mike and James yet again invite Adrienne to go over all the evidence for treating toenail onychomycosis. We find that ~ 40% more people get better on oral treatments than on placebo. For topicals the number is closer to 10%. Topicals should likely only be used if there is <40% nail involvement. Show notes Tools For Practice...
Episode 439: Taking a hard look at the evidence: PDE5 inhibitors in erectile dysfunction
In episode 439, Mike and James invite Adrienne to take us through the impressively large amount of evidence for the PDE5 inhibitors for erectile dysfunction. We find that the NNTs are 2-3 for the not clearly defined endpoint of successful intercourse. There is a 20% absolute increase in adverse effects but almost no one stops using these medications because of these effects. Go figure....